Ontex International N.V. Medical Equipment
Company Share Analysis
| Publication Date | July 2008 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 23 |
| ISBN Number | not applicable |
| Product Code | GMD06481 |
Summary
ONTEX International N.V. Medical Equipment Company Share Analysis
Summary
This report is an essential source for data, analysis and strategic insight into ONTEX International N.V. The report provides key information relating to market share by sector and country. The report examines company's business structure and operations, history and products, and provides an analysis of its key revenue lines.
Scope
- Revenues for the markets and sub-sectors ONTEX International N.V. operates in by country and region.
- Detailed breakdowns of revenues and market share .
- Profiles of the pipeline of products that the company is developing.
- Provides summary analysis of key revenue lines and strategy.
- Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
- Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.
Reasons to buy
- A single source to fulfill all of your business and competitor intelligence needs
- Research your competitors business structure, strategy and prospects.
- Counter your competitors strengths and target their weaknesses.
- Identify your competitors key revenue streams by market and geography.
- Identify and assess potential corporate and investment opportunities
- Support sales activities by understanding your customers businesses better.
- Identify potential competitor products before they reach market.
- Qualify prospective partners and suppliers.
Content
- 1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 3 Definitions of the Markets/Categories Covered
- 3.1 Nephrology and Urology Devices
- 3.1.1 Incontinence Devices
- 3.1 Nephrology and Urology Devices
- 4 Company Snapshot
- 4.1 Key Information
- 4.2 Company Overview
- 5 Business Description
- 5.1 Business Overview
- 5.2 Major Products and Services
- 5.2.1 Overview
- 6 Competitors
- 7 ONTEX International N.V. Medical Equipment Market Share Analysis
- 7.1 ONTEX International N.V. Global, Nephrology and Urology Devices by category, Market Share (2007)
- 7.2 ONTEX International N.V. Europe, Nephrology and Urology Devices by category, Market Share (2007)
- 8 Company Statement
- 9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
- 10 Appendix
- 10.1 Global Markets Direct Research Methodology
- 10.2 Coverage
- 10.3 Secondary Research
- 10.4 Primary Research
- 10.5 Models
- 10.6 Forecasts
- 10.7 Expert Panels
- 10.8 Market Revenue Chapters
- 10.8.1 Abbreviations
- 10.8.2 Currency Conversions
- 10.9 About Global Markets Direct
- 10.10 Contact Us
- 10.11 Disclaimer
- 1.1 List of Tables
- Table 1: ONTEX International N.V, Key Facts
- Table 2 ONTEX International N.V. Incontinence Devices by Geography, Global, Revenue ($ mn) and Market Share (%), 2007
- Table 3: ONTEX International N.V. Incontinence Devices by Geography, Europe, Revenue ($ mn) and Market Share (%), 2007
- Table 4: ONTEX International N.V., Subsidiaries
- Table 5: Abbreviations used in the Market Revenue Chapters
- Table 6: Currency Conversion from USD to Local Currency at 2007 Constant Rate
- 1.2 List of Figures
- Figure 1: ONTEX International N.V. Nephrology and Urology Devices by Category, Europe, Share of Market (%), 2007
- Figure 2: Global Markets Direct Methodology
About this Product
Delivery Details
PDF:Delivered by email usually within 24 to 48 UK business hours.
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Profiles | In-depth Company Insight | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories
















